INTERNATIONAL PATENT: MODERNATX, INC., VERTEX PHARMACEUTICALS INCORPORATED FILES APPLICATION FOR "POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS"

GENEVA, June 4 -- MODERNATX, INC. (325 Binney StreetCambridge, Massachusetts 02142), VERTEX PHARMACEUTICALS INCORPORATED (50 NORTHERN AVENUEBoston, Massachusetts 02210) filed a patent application (PCT/US2024/056591) for "POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS" on Nov 20, 2024. With publication no. WO/2025/111297, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDREOTTA, Paulette W. (325 Binney StreetCambridge, Massachusetts 02142), BRANSFORD, Phil...